4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-046083
Chief Operating Officer sold 3,125 shares at an average $37.17 ($116,155)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ADAMS R MARK Chief Operating Officer | 2021-07-07 | Sale | −871 | $39.42 | $34,335 | 57,233 | D: show line 1 in the form |
| ADAMS R MARK Chief Operating Officer | 2021-07-08 | Sale | −2,254 | $36.30 | $81,820 | 54,979 | D: show line 2 in the form |
| Open-market sales · 3,125 sh · avg $37.17 · $116,155 | |||||||
Loading xslF345X03/doc4.xml…